$3.01
+0.11 (+3.79%)
Open$2.99
Previous Close$2.90
Day High$3.03
Day Low$2.83
52W High$8.54
52W Low$2.29
Volume—
Avg Volume191.9K
Market Cap128.69M
P/E Ratio—
EPS$-0.85
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+78.4% upside
Current
$3.01
$3.01
Target
$5.37
$5.37
$3.28
$5.37 avg
$6.50
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.7K | 97.3K | 62.40M |
| Net Income | -37,722,024 | -378,481,846 | -13,759,336 |
| Profit Margin | -401,812.5% | -381,721.9% | -22.1% |
| EBITDA | -38,686,123 | -409,719,251 | -15,040,886 |
| Free Cash Flow | — | — | -13,384,851 |
| Rev Growth | -91.0% | -91.0% | +12.2% |
| Debt/Equity | — | — | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |